BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9324292)

  • 1. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
    Lanza F; Castagnari B; Rigolin G; Moretti S; Latorraca A; Ferrari L; Bardi A; Castoldi G
    Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells.
    Lanza F; Castoldi GL; Castagnari B; Todd RF; Moretti S; Spisani S; Latorraca A; Focarile E; Roberti MG; Traniello S
    Br J Haematol; 1998 Oct; 103(1):110-23. PubMed ID: 9792297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
    Bradbury DA; Russell NH
    Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
    Bradbury DA; Zhu YM; Russell NH
    Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.
    Iwasaki-Arai J; Iwasaki H; Miyamoto T; Watanabe S; Akashi K
    J Exp Med; 2003 May; 197(10):1311-22. PubMed ID: 12756267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
    Terpstra W; Rozemuller H; Breems DA; Rombouts EJ; Prins A; FitzGerald DJ; Kreitman RJ; Wielenga JJ; Ploemacher RE; Löwenberg B; Hagenbeek A; Martens AC
    Blood; 1997 Nov; 90(9):3735-42. PubMed ID: 9345060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure.
    Dirksen U; Hattenhorst U; Schneider P; Schroten H; Göbel U; Böcking A; Müller KM; Murray R; Burdach S
    Blood; 1998 Aug; 92(4):1097-103. PubMed ID: 9694696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis.
    DiGiuseppe JA; LeBeau P; Augenbraun J; Borowitz MJ
    Am J Clin Pathol; 1996 Sep; 106(3):345-51. PubMed ID: 8816592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
    Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro.
    Schmetzer HM; Gerhartz HH; Wilmanns W
    Ann Hematol; 1999 Oct; 78(10):449-55. PubMed ID: 10550555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
    Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.